Clinical Trials Directory

Trials / Conditions / Crimean-Congo Hemorrhagic Fever

Crimean-Congo Hemorrhagic Fever

5 registered clinical trials studyying Crimean-Congo Hemorrhagic Fever — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingSafety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
NCT06799013
HDT BioPhase 1
Not Yet RecruitingUMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF
NCT06860334
Liverpool School of Tropical MedicinePhase 2
CompletedStudy to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever
NCT06684431
Karolinska InstitutetPhase 1
CompletedPhase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Develo
NCT03020771
The Scientific and Technological Research Council of TurkeyPhase 1
WithdrawnTreatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities
NCT00992693
U.S. Army Medical Research and Development CommandPhase 2